The Journal of Organic Chemistry
Article
(m, 4H), 5.31 (d, J = 7.0 Hz, 1H), 5.29 (d, J = 6.8 Hz, 1H), 4.93 (d, J =
7.5 Hz, 1H), 4.92 (d, J = 7.4 Hz, 1H), 3.85 (t, J = 9.8 Hz, 1H), 1.96 (t, J =
6.7 Hz, 1H), 1.95 (br s, 1H) ppm. 13C NMR (125 MHz, CDCl3, d1 = 4.0
s) δ 179.3, 149.1, 140.1, 131.8, 130.8, 129.2, 126.4, 125.9, 124.1, 118.9,
117.0, 111.3, 111.2, 92.8, 48.9, 40.6 ppm (one signal missing because of
overlap). Anal. Calcd for C25H19N3O2 (393.44): C, 76.32; H, 4.87; N,
10.68. Found: C, 76.24; H, 4.59; N, 10.65. HRMS (ESP+): m/z
416.1414 [MNa+], calcd for (C25H19N3O2Na+): m/z 416.1369.
2-(4-Bromophenyl)azulene-1-carbonitrile (9.8). For preparation,
see the synthesis of compound 1.10.
7-Bromo-2-(4′-nitrophenyl)-1,8a-dihydroazulene-1,1-dicarboni-
trile (11.1). To a stirred solution of freshly prepared dibromide 10.1
(218 mg, 0.473 mmol) in dry THF (10 mL, <15 ppm H2O) under an
argon atmosphere at 0 °C was added a solution of LiHMDS (0.60 mL,
0.47 mmol, 1.0 M) in toluene dropwise. The reaction mixture was stirred
for 1 h as the temperature was allowed to reach rt. The reaction mixture
was diluted with Et2O (100 mL), washed with saturated aqueous NH4Cl
(2 × 50 mL), dried with MgSO4, and filtered. Evaporation of the
solvents gave 11a as a black solid with minor impurities. An analytically
pure sample was obtained by purification by dry column vacuum
chromatography (SiO2, 12.6 cm2, 0−40% THF/heptanes, 5% steps,
40 mL fractions) followed by recrystallization from CHCl3/heptanes
(3:5), which gave 11a (42.9 mg, 0.113 mmol, 24%) as yellow crystals,
with some suitable for X-ray crystallography. mp 172.5−174.5 °C.1 1H
NMR (500 MHz, CDCl3) δ 8.34 (d, J = 9.0 Hz, 2H), 7.89 (d, J = 9.0 Hz,
2H), 7.06 (s, 1H), 6.63−6.54 (m, 2H), 6.44 (dd, J = 6.0 Hz, 1.7 Hz, 1H),
6.12 (d, J = 4.4 Hz, 1H), 3.84 (dd, J = 4.4, 1.7 Hz, 1H) ppm. 13C NMR
(125 MHz, CDCl3) δ 148.5, 140.1, 139.0, 136.1, 135.5, 134.3, 131.9,
127.3, 124.7, 122.5, 120.4, 120.1, 114.1, 111.9, 51.1, 44.7 ppm. Anal.
Calcd for C18H13N3O2 (303.31): C, 56.86; H, 2.65; N, 11.05. Found: C,
56.27; H, 2.31; N, 10.78. MS (MALDI−): m/z 379, 381 [M−Br79/81].
UV−vis (MeCN) λDHA : 378 nm. λVHF: 476 nm.
7-Bromo-2-(4′-tolyl)-1,8a-dihydroazulene-1,1-dicarbonitrile
(11.3). Prepared according to the general procedure for 11.1: to 10.3
(860 mg, 2.00 mmol) in dry THF (20 mL) was added a solution of
LiHMDS (2.00 mL, 2.00 mL, 1 M) in toluene, which yielded 11.3
(>90% purity) as a black oil. An analytically pure sample was obtained by
purification by dry column vacuum chromatography (SiO2, 12.6 cm2, 0−
40% THF/heptanes, 5% steps, 40 mL fractions) to give 11.3 (517 mg,
1.48 mmol, 74%) as a yellow solid. mp 167.7−169.1 °C dec. 1H NMR
(500 MHz, CDCl3) δ 7.63 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 8.2 Hz, 2H),
6.84 (s, 1H), 6.53−6.50 (m, 2H), 6.30−6.27 (m, 1H), 6.12 (d, J = 4.4
Hz, 1H), 3.78 (dd, J = 4.4, 1.8 Hz, 1H), 2.41 (s, 3H) ppm. 13C NMR
(125 MHz, CDCl3) δ 142.0, 141.4, 141.3, 132.7, 132.2, 130.7, 130.2,
127.4, 126.5, 120.3, 120.0, 119.6, 114.8, 112.6, 51.2, 44.8, 21.6 ppm.
Anal. Calcd for C19H13N2Br (349.22): C, 65.35; H, 3.75; N, 8.02.
Found: C, 65.23; H, 3.50; N, 8.01. MS (MALDI TOF+): m/z 348, 350
[M+ 79/81Br]. UV−vis (MeCN) λDHA: 362 nm. λVHF: 471 nm.
2-(4′-Bromophenyl)-7-bromo-1,8a-dihydroazulene-1,1-dicarbo-
nitrile (11.8). Prepared according to the general procedure for 11.1: to
10.8 (1.00 g, 2.03 mmol) in dry THF (40 mL) was added a solution of
LiHMDS (2.00 mL, 2.00 mmol, 1 M) in toluene, which yielded 11f
(>90% purity) as a black oil with minor impurities. Purification by
dry column vacuum chromatography (SiO2, 12.6 cm2, 0−40% THF/
heptanes, 5% steps, 40 mL fractions) followed by a recrystallization from
CHCl3 and heptanes gave 11f (596 mg, 1.44 mmol, 72%) as a dark
yellow solid. mp 184.5−186.8 °C. 1H NMR (500 MHz, CDCl3) δ 7.63−
7.58 (m, 2H), 6.89 (s, 1H), 6.58−6.50 (m, 2H), 6.34 (d, J = 5.8 Hz, 1H),
6.11 (d, J = 4.4 Hz, 1H), 3.80 (dd, J = 4.4, 1.7 Hz, 1H) ppm. 13C NMR
(125 MHz, CDCl3) δ 140.8, 140.6, 133.3, 132.8, 132.3, 132.1, 129.1, 127.9,
125.1, 120.6, 120.3, 120.1, 114.5, 112.3, 51.1, 44.7 ppm. Anal. Calcd for
C18H10Br2N2 (414.09): C, 52.21; H, 2.43; N, 6.76. Found: C, 52.04; H,
2.22; N, 6.71. UV−vis (MeCN) λDHA: 360 nm. λVHF: 467 nm.
7-Bromo-2-(4′-cyanophenyl)-1,8a-dihydroazulene-1,1-dicarboni-
trile (11.10). Prepared according to the general procedure for 11.1: to
10.10 (350 mg, 0.80 mmol) in dry THF (20 mL) was added a solution
of LiHMDS (0.80 mL, 0.80 mmol, 1 M) in toluene, which yielded 11.10
as a black solid with minor impurities. Purification by dry column
vacuum chromatography (SiO2, 12.6 cm2, 0−40% THF/heptanes, 5%
steps, 40 mL fractions) followed by a recrystallization from CHCl3 and
heptanes gave 11.10 (184 mg, 0.512 mmol, 64%) as a yellow solid. 1H
NMR (500 MHz, CDCl3) δ 7.83 (d, J = 8.8 Hz, 2H), 7.78 (d, J = 8.8 Hz,
2H), 7.01 (s, 1H), 6.61 (d, J = 11.6 Hz, 1H), 6.55 (dd, J = 11.6, 6.1 Hz,
1H), 6.42 (dd, J = 6.1, 1.8 Hz, 1H), 6.12 (d, J = 4.4 Hz, 1H), 3.83 (dd, J =
4.4, 1.8 Hz, 1H).13C NMR (125 MHz, CDCl3) δ 140.1, 139.4, 134.8,
134.3, 134.1, 133.2, 131.9, 127.0, 122.2, 120.4, 120.1, 118.1, 114.2, 113.9,
112.00, 51.1, 44.6 ppm. Anal. Calcd for C19H10N3Br (360.21): C, 63.35;
H, 2.80; N, 11.67. Found: C, 63.45; H, 2.49; N, 11.45. HRMS
(ESP+): m/z 740.9994 (51), 742.0012 (22), 742.9987 (100),
744.0017 (45), 744.9974 (54), 745.9981 (23) [2MNa+ 79/81Br], calcd for
2-(4-Cyanophenyl)azulene-1-carbonitrile (9.10). For preparation,
see the synthesis of compound 1.10.
2-(4′-Nitrophenyl)-7,8-dibromo-7,8,1,8a-tetrahydroazulene-1,1-
dicarbonitrile (10.1). To a stirred solution of DHA 1.1 (143 mg,
0.473 mmol) in CH2Cl2 (5 mL) under an argon atmosphere at −78 °C
was added a solution of Br2 in CH2Cl2 (0.61 mL, 0.78 M, 0.47 mmol)
dropwise. The brown mixture was then stirred for 30 min, after which
the solution took a yellow color. Evaporation of the solvents gave
dibromide 10.1 (218 mg, 0.47 mmol, >99%) as a yellow solid. 1H NMR
(500 MHz, CDCl3) δ 8.35 (d, J = 9.0 Hz, 2H), 7.91 (d, J = 9.0 Hz, 2H),
7.15 (s, 1H), 6.42 (dd, J = 7.5, 2.3 Hz, 1H), 6.13 (dd, J = 12.2, 7.5 Hz,
1H), 6.00 (dd, J = 12.2, 5.6 Hz, 1H), 5.32−5.30 (m, 1H), 5.05−5.04 (m,
1H), 4.70 (br s, 1H) ppm. 13C NMR (125 MHz, CDCl3) δ 148.3, 143.9,
137.9, 137.1, 136.0, 130.2, 127.2, 125.5, 124.8, 123.9, 114.2, 111.3, 53.3,
51.0, 48.9, 44.6 ppm. Anal. Calcd for C18H13N3O2 (303.31): C, 46.89; H,
2.40; N, 9.11. Found: C, 46.94; H, 2.31; N, 8.82.
2-(4′-Tolyl)-7,8-dibromo-7,8,1,8a-tetrahydroazulene-1,1-dicarbo-
nitrile (10.3). To a stirred solution of DHA 1.3 (560.1 mg, 2.07 mmol)
in CH2Cl2 (40 mL) under an argon atmosphere at −78 °C was added a
solution of Br2 in CH2Cl2 (2.65 mL, 2.07 mmol, 0.78 M) dropwise. The
solution was stirred for 30 min, after which the solvent was removed in
vacuo, which gave 10.3 (891 mg, 2.07 mmol, >99%) as a dark yellow
1
solid. H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.2 Hz, 2H), 7.28
(d, J = 8.2 Hz, 2H), 6.92 (s, 1H), 6.23 (dd, J = 7.6, 2.2 Hz, 1H), 6.08 (dd,
J = 12.1, 7.6 Hz, 1H), 5.89 (dd, J = 12.1, 5.6 Hz, 1H), 5.34−5.30 (m,
1H), 5.06−5.03 (m, 1H), 4.64 (br s, 1H), 2.41 (s, 3H) ppm. 13C NMR
(125 MHz, CDCl3) δ 144.8, 141.0, 140.0, 133.1, 130.2, 128.3, 127.4,
126.4, 126.0, 120.6, 114.8, 111.9, 53.3, 51.7, 49.3, 44.7, 21.6 ppm. Anal.
Calcd for C19H14N2Br2 (430.14): C, 53.05; H, 3.28; N, 6.51. Found: C,
52.73; H, 3.05; N, 6.31.
2-(4′-Bromophenyl)-7,8-dibromo-1,7,8,8a-tetrahydroazulene-
1,1-dicarbonitrile (10.8). To a stirred solution of DHA 1.8 (679.7 mg,
2.028 mmol) in CH2Cl2 (40 mL) under an argon atmosphere, excluded
from light and cooled to −78 °C, was added a solution of Br2 in CH2Cl2
(2.62 mL, 0.78 M, 2.03 mmol) dropwise. The brown mixture was then
stirred for 30 min, after which the solution took a yellow color.
Evaporation of the solvents gave dibromide 10.8 (1.00 g, 2.03 mmol,
1
> 99%) as a yellow solid. mp 130−150 °C dec. H NMR (500 MHz,
CDCl3) δ 7.61 (br s, 4H), 6.97 (s, 1H), 6.29 (dd, J = 7.5, 2.3 Hz, 1H),
6.09 (dd, J = 12.2, 7.5 Hz, 1H), 5.93 (dd, J = 12.2, 5.7 Hz, 1H), 5.33−
5.28 (m, 1H), 5.06−5.02 (m, 1H), 4.65 (s, 1H) ppm. 13C NMR
(125 MHz, CDCl3) δ 144.4, 138.6, 134.7, 132.8, 129.1, 129.0, 127.9,
125.8, 124.9, 121.8, 114.5, 111.6, 53.3, 51.4, 49.1, 44.6 ppm. Anal. Calcd
for C19H14N2Br2 · 0.2 CH2Cl2 (511.99): C, 42.70; H, 2.24; N, 5.47.
Found: C, 43.07; H, 1.87; N, 5.54.
2-(4′-Cyanophenyl)-7,8-dibromo-7,8,1,8a-tetrahydroazulene-
1,1-dicarbonitrile (10.10). To a stirred solution of DHA 10.10 (284.3
mg, 1.011 mmol) in CH2Cl2 (30 mL) under an argon atmosphere and
cooled to −78 °C was added a solution of Br2 in CH2Cl2 (1.29 mL,
1.01 mmol, 0.78 M) dropwise. The solution was stirred for 30 min, after
which the solvent was removed in vacuo, which gave 10.10 (445.8 mg,
1
1.011 mmol, >99%) as a yellow solid or foam. H NMR (500 MHz,
CDCl3) δ 7.85 (d, J = 8.7 Hz, 2H), 7.77 (d, J = 8.7 Hz, 2H), 7.10 (s, 1H),
6.38 (dd, J = 7.5, 2.3 Hz, 1H), 6.12 (dd, J = 12.2, 7.5 Hz, 1H), 5.99 (dd,
J = 12.2, 5.5 Hz, 1H), 5.35−5.27 (m, 1H), 5.08−5.00 (m, 1H), 4.68
(s, 1H) ppm. 13C NMR (125 MHz, CDCl3) δ 143.9, 137.4, 137.2, 134.3,
133.2, 129.9, 126.9, 125.5, 123.5, 118.1, 114.2, 113.6, 111.4, 53.3, 51.1,
48.9, 44.5 ppm. Anal. Calcd for C19H11N3Br2 (441.12): C, 51.73; H,
2.51; N, 9.53. Found: C, 51.73; H, 2.39; N, 9.54.
63
dx.doi.org/10.1021/jo4020326 | J. Org. Chem. 2014, 79, 41−64